Abstract
To investigate the clinical manifestations and outcomes of musculoskeletal (MSK) nontuberculous mycobacterium (NTM) infections. This study was a retrospective cohort study using the Siriraj Hospital database from 2005 to 2017. Enrolled were all patients aged 15 or older who had an MSK infection with NTM identified in synovial fluid, pus, or tissue by an acid-fast bacilli stain, culture, or polymerase chain reaction. Of 1529 cases who were diagnosed with NTM infections, 39 (2.6%) had an MSK infection. However, only 28 patients met our inclusion criteria. Their mean age (SD) was 54.1 (16.1) years, and half were male. Of this cohort, 25% had previous musculoskeletal trauma, 18% prior bone and joint surgery, 14% prosthetic joint replacement, and 11% HIV infection. The median symptom duration (IQR) was 16 (37.4) weeks. The most common MSK manifestation was arthritis (61%), followed by osteomyelitis (50%), tenosynovitis (25%), and spondylodiscitis (14%). The most common organism was M. abscessus (18%), and M. kansasii (18%), followed by M. intracellulare (14%), M. marinum (14%), M. fortuitum (7%), and M. haemophilum (7%). In addition to medical treatment, most patients underwent surgery (82%), comprising debridement, osteotomy, prosthesis removal, and amputation, while 18% received only medical treatment. The treatment outcomes were complete recovery in 46%, improvement with some residual disability and deformities in 29%, and death in 3.6%. Musculoskeletal NTM infections were uncommon. Most patients had underlying joint disease or were immunocompromised hosts. Surgical management, as an adjunct to medical therapy, was necessary.
Similar content being viewed by others
References
Ploenchan C, Sasisopin K, Piroon M, Susun A (2007) Disseminated nontuberculous mycobacterial infection in patients without HIV infection. Clin Infect Dis 45:421–427
Lai CC, Tan CK, Chou CH et al (2010) Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008. Emerg Infect Dis 16:294–296
Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Petitjean G, Fluckiger U, Scharen S et al (2004) Vertebral osteomyelitis caused by non-tuberculous mycobacteria. Clin Microbiol Infect 10:951–953
Winthrop KL, Chang E, Yamashita S et al (2009) Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 15:1556–1561
Salvana EM, Cooper GS, Salata RA (2007) Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect 55:484–487
Piersimoni C, Scarparo C (2009) Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis 15:1351–1358
Kelly PJ, Karlson AG, Weed LA et al (1967) Infection of synovial tissues by mycobacteria other than Mycobacterium tuberculosis. J Bone Joint Surg Am 49:1521–1530
Marchevsky AM, Damsker B, Green S et al (1985) The clinicopathological spectrum of non-tuberculous mycobacterial osteoarticular infections. J Bone Joint Surg Am 67:925–929
Zenone T, Boibieux A, Tigaud S et al (1999) Non-tuberculous mycobacterial tenosynovitis: a review. Scand J Infect Dis 31:221–228
Hsiao CH, Cheng A, Huang YT et al (2013) Clinical and pathological characteristics of mycobacterial tenosynovitis and arthritis. Infection 41:457–464
Sutker WL, Lankford LL, Tompsett R (1979) Granulomatous synovitis: the role of atypical mycobacteria. Rev Infect Dis 1:729–735
Chan ED, Kong PM, Fennelly K et al (2001) Vertebral osteomyelitis due to infection with nontuberculous Mycobacterium species after blunt trauma to the back: 3 examples of the principle of locus minoris resistentiae. Clin Infect Dis 32:1506–1510
Sheng B, Fei-Shu H, Hai-Ying Y et al (2015) Nontuberculous mycobacterial osteomyelitis. Infect Dis 47:673–685
Danchaivijitr N, Temram S, Thepmongkhol K, Chiewvit P (2007) Diagnostic accuracy of MR imaging in tuberculous spondylitis. J Med Assoc Thai 90:1581–1589
Kampmann B, Hemingway C, Stephens A et al (2005) Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Investig 115:2480–2488
Acknowledgements
The authors gratefully acknowledge Ms. Khemajira Karaketklang of the Research and Academic Services Unit, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University for assistance with statistical analysis.
Funding
This study is unfunded.
Author information
Authors and Affiliations
Contributions
CN and WK made substantial contributions to the conception, design of the work, the acquisition, analysis, interpretation of data, drafted the work or substantively revised it, approved the submitted version and take full responsibility for the integrity of the study and the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Author Wanruchada Katchamart and Author Chaikiat Napaumpaiporn declares that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standard (Siriraj Institutional Review Broad, COA no. Si 63812018, Approval date: October 10, 2018).
Informed consent
Informed consent was not obtained from all individual participants included in the study because this study is a retrospective chart review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Napaumpaiporn, C., Katchamart, W. Clinical manifestations and outcomes of musculoskeletal nontuberculous mycobacterial infections. Rheumatol Int 39, 1783–1787 (2019). https://doi.org/10.1007/s00296-019-04392-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-019-04392-8